# Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation

> **NCT01190059** · PHASE1 · COMPLETED · sponsor: **XVIVO Perfusion** · enrollment: 22 (actual)

## Conditions studied

- Lung Transplantation

## Interventions

- **DRUG:** Ex vivo lung perfusion with Steen Solution™

## Key facts

- **NCT ID:** NCT01190059
- **Lead sponsor:** XVIVO Perfusion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01190059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01190059, "Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01190059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*